![An AI Invasion: Improving Breast Cancer Biopsies](https://www.g2intelligence.com/wp-content/uploads/2023/01/Feb23.DTET_.Cancer-and-AI-iStock-1800x1250-1-1080x675.jpg)
An AI Invasion: Improving Breast Cancer Biopsies
Researchers report the first-ever routine clinical use of an AI-based tool for breast cancer biopsies in a pathology lab.
Researchers report the first-ever routine clinical use of an AI-based tool for breast cancer biopsies in a pathology lab.
Key Dx announcements last week involved companion diagnostics, liquid biopsy assays, and an RUO leukemia test.
DNA sequencing technologies may revolutionize the early detection and prevention of the disease.
Circulating tumor DNA sequencing technologies are tackling the challenges of early cancer detection.
A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.